Ignite Creation Date:
2024-05-06 @ 2:37 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04370288
Status:
UNKNOWN
Last Update Posted:
2020-05-04
First Post:
2020-04-29
Brief Title:
Clinical Application of Methylene Blue for Treatment of Covid-19 Patients
Sponsor:
Mashhad University of Medical Sciences
Organization:
Mashhad University of Medical Sciences
Study Overview
Official Title:
The Clinical Trial of Application of Methylene Blue Vial for Treatment of Covid-19 Patients
Status:
UNKNOWN
Status Verified Date:
2020-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Covid-19
Brief Summary:
The severe acute respiratory syndrome caused by COVID-19 is now a global catastrophic event Currently there is no approved drug or vaccine for the disease Methylene blue MB oxidized form blue color has been used in many different areas of clinical medicine ranging from malaria to orthopedics Leucomethylene Blue reduced form of MB colorless may be applied for the treatment of COVID-19 according to the scientific evidences
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None